Edition:
United Kingdom

People: Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

133.75SEK
24 May 2019
Change (% chg)

1.55kr (+1.17%)
Prev Close
132.20kr
Open
132.20kr
Day's High
134.95kr
Day's Low
132.20kr
Volume
738,365
Avg. Vol
1,194,530
52-wk High
137.65kr
52-wk Low
74.74kr

Viebke, Jens 

Mr. Jens Viebke has been President, Acute Care Therapies at Getinge AB since June 6, 2016. Mr. Jens Viebke most recently served as Chief Technology Officer at Acute Care Therapies and was previously the President of the Critical Care division in the Group’s former Medical Systems business area. He joined the Company in 2010. He has long and broad experience from the healthcare industry and has previously held positions in research and development, as well as strategy and marketing, at other large companies in the industry, including GE Healthcare Life Sciences and Pharmacia & Upjohn. He holds a PhD in Polymer Technology from the Royal Institute of Technology of Stockholm and holds an Executive MBA from the Stockholm School of Economics. He is also Civil Engineer in Chemistry.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Johan Malmquist

684,000

Mattias Perjos

33,560,000

Carl Bennet

1,309,000

Johan Stern

684,000

Lars Sandstrom

--

Magnus Lundback

--
As Of  31 Dec 2018